CONDITION
Anaemia of Chronic Disease
Anaemia of chronic disease is a pattern in which the body's red blood cell count drops as part of its response to ongoing inflammation, infection, or illness elsewhere. The marrow has the capacity to make new cells, but iron becomes trapped inside storage cells and signalling changes mean fewer red cells are released into circulation. This type of anaemia tends to develop gradually over weeks or months, rather than suddenly. Owners may notice subtle changes—less enthusiasm for walks, sleeping more, or pale gums—but often the anaemia is detected on blood tests run for another reason, such as investigating weight loss, recurring infections, or a known chronic condition like kidney disease or immune-mediated illness. Because the anaemia is mild to moderate in many cases, signs can be easy to miss at first. This page explores the signals that may prompt investigation, the mechanisms that link inflammation to reduced red cell numbers, how anaemia of chronic disease is distinguished from other causes of low red cell counts, and the approaches taken when this pattern is identified. The focus is always on the underlying condition driving the process.
Why this matters now
Anaemia of chronic disease can develop at any age, but tends to be recognised more often in middle-aged and older animals, reflecting the increased likelihood of chronic inflammatory or immune-mediated conditions, kidney disease, and cancer in those life stages. There is no consistent breed predisposition, though breeds at higher risk for the underlying conditions—such as autoimmune disease or certain cancers—may be more likely to show this pattern. The anaemia itself emerges as a secondary consequence of weeks to months of ongoing inflammation, rather than as a standalone disease.
The anaemia typically develops slowly, keeping pace with the underlying condition rather than appearing suddenly. Red cell numbers decline gradually as iron is sequestered and production signals shift, so the body often has time to adapt and clinical signs may remain subtle for some time. If the underlying disease worsens or persists, the anaemia may become more pronounced, though it rarely reaches severe levels unless compounded by other factors such as blood loss or kidney failure. In some cases, successful management of the primary condition can lead to stabilisation or even partial recovery of red cell counts over weeks to months.
Signals & patterns
Early signals
Reduced stamina on walks
An owner may notice their dog tires more quickly than usual, choosing to slow down or stop during a route they previously managed comfortably. This reflects the reduced oxygen-carrying capacity of the blood, though the change is often gradual enough to be attributed to ageing or weather at first.
Increased time spent resting
Cats and dogs may sleep more during the day or seem less interested in play or interaction. Because the shift is often subtle and develops over weeks, it can be easy to overlook, particularly in older animals whose activity levels may already vary.
Paler mucous membranes
The gums, inner eyelids, or tongue may appear lighter pink than usual, though this can be difficult to assess in animals with naturally pale or pigmented tissues. The change reflects fewer red blood cells circulating near the surface, but many owners may not notice it without a direct comparison to earlier months.
Weight loss or poor appetite
Loss of interest in food or gradual weight decline often reflects the underlying chronic condition rather than the anaemia itself. Because anaemia of chronic disease is a response to another illness, these signs may be among the first to prompt investigation, with the anaemia discovered incidentally on blood tests.
Later signals
Noticeably pale or white gums
As red cell numbers fall further, the mucous membranes may become strikingly pale or even white. This tends to occur when the anaemia has progressed beyond mild levels, or when it is compounded by other factors such as ongoing blood loss or worsening kidney function.
Reluctance to move or exercise intolerance
Some animals may become visibly reluctant to climb stairs, jump, or engage in normal activity, reflecting the reduced oxygen delivery to muscles and organs. This pattern is more common when the anaemia is moderate to marked, or when the underlying disease is also limiting mobility or causing discomfort.
Increased breathing rate at rest
The body may compensate for reduced oxygen-carrying capacity by breathing more frequently, even when the animal is lying quietly. This sign is more likely when anaemia is pronounced or develops alongside heart or lung involvement from the primary condition.
Click to read about the biological mechanisms
How this is usually investigated
Investigation typically begins with a review of the animal's history and any known chronic conditions, followed by blood tests that reveal the anaemia alongside other changes. The pattern that emerges—mild to moderate anaemia with normal-sized red cells, low reticulocyte response, and often low serum iron despite adequate iron stores—points towards anaemia of chronic disease rather than blood loss or iron deficiency. Further tests then focus on identifying or characterising the underlying inflammatory, infectious, or neoplastic process driving the pattern.
Complete blood count
Reticulocyte count
Chemistry panel
Serum protein electrophoresis
Abdominal ultrasound
Options & trade-offs
Management is directed at the underlying condition rather than the anaemia itself, since the red cell count tends to stabilise or improve as inflammation resolves. The combination of approaches depends on what is driving the process—whether infection, immune-mediated disease, cancer, or organ dysfunction—and what is practical for the individual animal and household. Some conditions can be controlled or cured, while others are managed over months to years with the aim of reducing inflammation and preserving quality of life.
Treatment of the underlying condition
When the primary disease is identified—such as a chronic infection, immune-mediated disorder, or cancer—targeted treatment can reduce inflammation and allow red cell production to recover. This may involve antimicrobials, immunosuppressive drugs, chemotherapy, or surgery, depending on the diagnosis. As hepcidin levels fall and erythropoietin signalling improves, red cell counts often rise gradually over weeks to months.
Trade-offs: Response depends on how well the underlying condition can be controlled, and some diseases are easier to manage than others. Treatment may involve ongoing medication, monitoring visits, and the possibility of side effects or incomplete response.
Supportive adjustments to reduce metabolic demand
Reducing physical exertion, ensuring good nutrition, and managing concurrent conditions such as dental disease or parasitic infection can lessen the metabolic burden on an anaemic animal. While these measures do not resolve the anaemia directly, they can improve comfort and reduce clinical signs while the underlying condition is being addressed.
Trade-offs: Supportive care alone does not alter the course of the anaemia or the primary disease. It is most useful as part of a broader plan rather than as a standalone approach.
Monitoring without active intervention
In cases where the anaemia is mild, the animal shows few clinical signs, and the underlying condition is either stable or not amenable to treatment, periodic blood tests and observation may be chosen over active intervention. This allows assessment of whether the anaemia is progressing or remaining static, and whether quality of life is being maintained.
Trade-offs: This approach accepts a degree of anaemia and relies on the animal's ability to compensate. It may be less suitable if the underlying disease is progressive or if the anaemia worsens over time.
Supplementation or erythropoietic support in selected cases
In animals with concurrent kidney disease, synthetic erythropoietin may be considered to stimulate red cell production when endogenous levels are low. Iron supplementation is rarely helpful in anaemia of chronic disease, as iron is sequestered rather than depleted, but may be used if true iron deficiency coexists.
Trade-offs: Erythropoietin therapy requires careful dosing and monitoring, and may provoke antibody formation in some animals, leading to severe anaemia. Iron given when stores are already adequate does not improve red cell counts and may contribute to oxidative stress.
Common misconceptions
"Anaemia of chronic disease means the animal is iron-deficient and will benefit from iron supplementation."
In this pattern, iron is not depleted but trapped inside storage cells by the action of hepcidin. Supplementing iron when stores are already adequate does not improve red cell production and may add unnecessary metabolic burden. True iron deficiency is a separate condition, usually driven by blood loss, and can be distinguished by measuring iron stores.
"If the anaemia is mild, there is no need to investigate further because it is not causing harm."
Mild anaemia of chronic disease is itself a marker that an underlying inflammatory, infectious, or neoplastic process is present and has been ongoing for weeks to months. The anaemia may be well tolerated, but the condition driving it may require diagnosis and management in its own right. Identifying the cause can sometimes reveal treatable disease before it progresses.
"Once anaemia of chronic disease develops, the red cell count will never recover."
The anaemia is a consequence of altered iron handling and signalling, not a permanent marrow failure. If the underlying condition is successfully treated or controlled, hepcidin levels can fall and erythropoietin signalling can recover, allowing red cell counts to stabilise or improve over time. The degree of recovery depends on how well the primary disease responds to management.
Related conditions
Chronic Kidney Disease in Cats
Chronic kidney disease is one of the more common underlying conditions that can trigger anaemia of chronic disease, as ongoing kidney inflammation and impaired erythropoietin production both contribute to reduced red cell numbers. The anaemia in kidney disease often reflects a combination of this chronic inflammatory pattern and the kidney's direct role in stimulating red cell production.
Chronic Hepatitis in Dogs
Chronic hepatitis generates sustained inflammation that can drive the anaemia of chronic disease pattern, with inflammatory signalling affecting iron regulation and red cell production in the marrow. The liver's role in storing iron and producing proteins involved in iron transport means that ongoing liver disease may influence anaemia through multiple pathways.
Feline Leukaemia Virus (FeLV)
Feline leukaemia virus can produce anaemia through several mechanisms, including the chronic inflammatory state it establishes, direct effects on the bone marrow, and immune-mediated destruction of red cells. In some cats, the pattern overlaps with anaemia of chronic disease, particularly when the infection has persisted for months or years without causing more acute marrow suppression.
Alimentary Lymphoma in Cats
Alimentary lymphoma can drive anaemia of chronic disease through the sustained inflammation it creates in the gastrointestinal tract, alongside potential effects on nutrient absorption and the systemic immune response. The anaemia may be one of several gradual changes that prompt investigation, often appearing alongside weight loss or altered appetite.
Because anaemia of chronic disease reflects an underlying process rather than a disease in itself, the focus often shifts to understanding what is driving the inflammation and what can be done to manage it. Conversations about the primary condition—its likely course, the range of management options, and what monitoring may involve over time—can help clarify what to expect and what adjustments may be useful. In some cases, the anaemia becomes a useful marker of whether the underlying disease is responding to treatment or progressing.
Last reviewed: 13 September 2026 · Dr Alastair Greenway MRCVS